Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Caprion-HistoGeneX Expands its Histological Biomarker Franchise by Joining Forces with Mosaic Laboratories 2021-01-12 21:20
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
IKEUCHI Launches New Fogging Device for Quick, Easy and Effective Disinfection 2021-01-12 16:00
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer 2021-01-12 13:02
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
ClearMind Biomedical's Axonpen Neuroendoscope Receives 510K Clearance 2021-01-12 01:00
Regent Pacific Announces Key Research Findings On FORTACIN™ 2021-01-11 23:36
Korea Fair Trade Commission Assigns Compliance Program Rating of "A" to Yuyu Pharma 2021-01-11 22:00
PharmAbcine announces a research collaboration with LegoChem Biosciences 2021-01-11 21:00
Announcing Calyx: Advancing Clinical Research Through Technology-Enabled Services 2021-01-11 19:05
Airnov Made Its Debut at CPhI China 2021-01-11 16:26
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA. 2021-01-11 11:33
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-11 07:26
Standigm and SK Chemicals Repurpose FDA-approved Drug into Rheumatoid Arthritis Candidate and Apply for Patent through their Open Innovation Partnership 2021-01-11 07:00
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients 2021-01-10 16:55
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China 2021-01-09 11:06
Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences 2021-01-09 08:55
NTC grants to Zhaoke exclusive license and distribution rights in Asia for NTC014, innovative drug for bacterial conjunctivitis 2021-01-08 20:55
1 636 637 638 639 640 1097